Invests in
Sectors:
Min Investment:
$10,000,000.00Max Investment:
$40,000,000.00Target Investment:
$20,000,000.00
Skills
Education
- PU
Investments
Glystn
Total Funding: $4M
Toya Pioneering Women
Total Funding: $4M
Pendulum Therapeutics
Total Funding: $110M
GENETICA® US
Total Funding: $3M
Aledade
Total Funding: $550M
Roblox
Total Funding: $850M
Neuehealth
Total Funding: $2.3B
10X Genomics
Total Funding: $220M
Niantic
Total Funding: $750M
Glint
Total Funding: $80M
Work Experience
2011
Managing Director
2011
Helping entrepreneurs grow great companies they can tell their grandkids about.
2018
Board Observer
2018
Serge, Ben and Kevin built and took public a company that is revolutionizing multiple areas of biology - no hyperbole. The 10x teams work is already leading to life-saving discoveries and will ultimately impact hundreds of millions of lives.
2017
Investor
2017
2012
Board Observer
2012
2011
Angel Investor
2011
Angel Investor
2010
Tom and team are the first to ever create micro-stents to treat Glaucoma. The stents are tiny (the smallest medical devices ever approved by the FDA and nearly invisible to the naked eye) but Glaukos' impact on people's sight is huge. Glaukos went public in 2015 (GKOS).
2010
Angel Investor
2010
2007
Board Member and Angel Investor
2007
2011
Angel Investor
2011
2012
Angel Investor
2012